Targeting the Tumor Microenvironment with Gene-Engineered Immune Cells: Focus on CAR-Macrophages and CAR-NK Cells – A Review Article
The TME is a culprit of immunosuppression and a significant hurdle to long-term immunotherapeutic success in solid tumors, which are often associated with a dense stroma, hypoxia, and immunosuppressive myeloid and lymphoid cells. Conventional CAR-T cells tend to fail in this scenario as they are su...
I tiakina i:
| Kaituhi matua: | |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Health Innovation Press
2025-10-01
|
| Rangatū: | Health Innovation Reports |
| Ngā marau: | |
| Urunga tuihono: | https://healthinnovationpress.com/index.php/hir/article/view/54 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|